abstract |
Cannabinoid derivatives according to formula (I) are disclosed n n n n n n n n n n wherein, X, Y, R 1 , R 2 , and W can have the definitions provided herein. Without limitation, use of such compounds, their salts or pro-drug, or compositions containing the compounds, salts, or pro-drug, to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors. |